Nobio - The Future of Dental Materials: Long Term Antimicrobial Protection


Bacteria is the main cause for failure of many dental treatments, particularly restorations. Common antimicrobials, like chlorhexidine, fluorides or silvers, kill bacteria by release mechanism, so the effect is short-term (because they deplete), weakens the material (causes mass loss), and interferes with the flora balance. Scientists from Hadassah Medical Center and Tel-Aviv University in Israel developed a breakthrough antimicrobial technology that kills bacteria on contact, without releasing any chemicals. It stays active long-term (theoretically forever), without compromising the material’s mechanical properties or the natural flora.

The technology was tested in many dental materials (composites, adhesives, liners, cements and sealants), including 2 clinical trials, and published in 22 articles. Israel-based Nobio Ltd. acquired the technology and incorporated it into a line of premium dental materials, called Infinix™.  The company says it expects to launch Infinix™ this year, while also collaborating with major manufacturers who want this technology incorporated into their products.








Via Dell'industria, 65
01100 Viterbo - Italy
T +39 0761 352198
F +39 0761 352133
VAT: IT01612570562

INFODENT SRL has been operating in the dental market for 20 years. Our main product is INFODENT INTERNATIONAL B2B magazine, mailed worldwide to 20,500 companies in the dental trade and industry.We provide customised B2B marketing services and consultancy to help companies in the dental trade and industry find international partners, expand into new markets and promote their brand on an international scale.Since 2003 we have expanded our activity to the whole medical sector through INFOMEDIX INTERNATIONAL, our B2B medical magazine, and a range of related marketing services.

© 2012 Infodent International. - All rights reserved

Forgot your password? Enter the email address for your account.
An email will be sent allowing you to reset it.